Display options
Share it on

JRSM Open. 2014 May 06;5(6):2054270414531126. doi: 10.1177/2054270414531126. eCollection 2014 Jun.

Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopenia.

JRSM open

Kriti Mittal, Michael J McNamara, Brian R Curtis, Keith R McCrae

Affiliations

  1. Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio 44195, USA.
  2. Blood Center of Wisconsin, Milwaukee, Wisconsin 53233, USA.

PMID: 25057402 PMCID: PMC4100227 DOI: 10.1177/2054270414531126

Abstract

Drug-induced immune thrombocytopenia may be potentially fatal; here we report the development of severe thrombocytopenia with strong oxaliplatin-dependent antiplatelet antibodies.

Keywords: drug-induced thrombocyto-penia; oxaliplatin; thrombocytopenia

References

  1. Anticancer Res. 2008 Sep-Oct;28(5B):3115-7 - PubMed
  2. Gastroenterol Clin Biol. 2006 May;30(5):797-8 - PubMed
  3. Jpn J Clin Oncol. 2011 Jan;41(1):125-9 - PubMed
  4. Blood. 2006 Aug 1;108(3):922-7 - PubMed
  5. Ann Oncol. 2012 Aug;23(8):1937-1942 - PubMed
  6. Cardiovasc Intervent Radiol. 2011 Feb;34 Suppl 2:S190-4 - PubMed
  7. Transfusion. 2004 Jun;44(6):838-43 - PubMed
  8. Am J Hematol. 2006 Mar;81(3):193-8 - PubMed
  9. N Engl J Med. 2007 Aug 9;357(6):580-7 - PubMed

Publication Types